+44-1518-081136Nanomedicine in the treatment of glioblastomas and neurological disorders
Joint Event on 2nd International Conference on Nanomaterials and Nanotechnology & 22nd International Conference on Advanced Nanoscience and Nanotechnology
May 16-17, 2019 | Prague, Czech Republic
Alain L Fymat
International Institute of Medicine and Science, USA
Posters & Accepted Abstracts : Mater Sci Nanotechnol
Abstract:
One of the most promising applications of nanomedicine principles is in clinical neuroscience, particularly in the treatment of glioblastomas and neurological disorders (epilepsy, Parkinson disease; Alzheimer disease, etc.). Here, specially-designed nanoparticles (NPs) delivered by speciallydesigned nanocarriers are able to cross the blood brain barrier to deliver their payload at pre-defined location(s) according to specified time- and dose-fractionations while remaining unnoticed by the immune system. I will discuss the several NPs utilized and their corresponding clinical advantages, including: Nutshells (that can be targeted to bond to cancerous cells by conjugated antibodies or peptides to anopheles' surfaces); platelet-coated NPs (that can deliver higher doses of medication drugs to targeted sites, thus greatly enhancing their therapeutic effects); biocompatible and biodegradable gelatin NPs (that can deliver multiple drugs); and shape-shifting engineered NPs (that can can be tailored to deliver drugs to specified tumors and nowhere else).
Biography:
E-mail:
alain.fymat@fiimas.orgPDF HTML